LiverLearning®: 2021 Webinar: Microbiome in NASH and Cirrhosis

In this one-hour webinar, learn about the pathophysiology of microbiome and liver disease, microbiome in NASH and microbiome in cirrhosis and other liver conditions.Suzanne Devkota Suzanne Devkota, PhD is Director of Microbiome Research at Cedars-Sinai Medical Center in Los Angeles and Assistant Professor of Medicine at UCLA, as well as an adjunct investigator at the Joslin Diabetes Center at Harvard Medical School.

Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis

Jonathon J. Graham, Sujit Mukherjee, Muhammad Yuksel, Rebeca Sanabria Mateos, Tengfei Si, Zhenlin Huang, Xiahong Huang, Hadil Abu Arqoub, Vishal Patel, Mark McPhail, Yoh Zen, Nigel Heaton, Maria Serena Longhi, Michael A. Heneghan, Rodrigo Liberal, Diego Vergani, Giorgina Mieli‐Vergani, Yun Ma, Bu’Hussain Hayee – 10 October 2021

Subscribe to